EurekAlert!, a service of AAAS
Home About us
Advanced Search
30-Oct-2014 11:20
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Bioinformatics

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 476-500 out of 714.

<< < 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 > >>

Public Release: 15-Aug-2013
Journal of Clinical Investigation
JCI early table of contents for Aug. 15, 2013
This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, Aug. 15, 2013, in the JCI: Biomarkers predict time to ovarian cancer recurrence, A molecule involved in development of chronic obstructive pulmonary disease, Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis and many more.

Contact: Corinne Williams
press_releases@the-jci.org
Journal of Clinical Investigation

Public Release: 14-Aug-2013
Nature
Cancer's origins revealed
Scientists have provided the first comprehensive genomic map of mutational processes that drive tumour development. Together, these mutational processes explain the majority of mutations found in 30 of the most common cancer types.

Contact: Aileen Sheehy
press.office@sanger.ac.uk
44-012-234-92368
Wellcome Trust Sanger Institute

Public Release: 11-Aug-2013
Nature
NIH-funded study discovers new genes for childhood epilepsies
A genetic study of childhood epilepsies has linked two new genes to severe forms of disease and provides a novel strategy for identifying therapy targets. The results suggest this may be a highly effective way to find and confirm many disease-causing gene mutations.
NIH/National Institute of Neurological Disorders and Stroke, Finding a Cure for Epilepsy and Seizures, Richard Thalheimer Philanthropic Fund

Contact: Christopher Thomas
nindspressteam@ninds.nih.gov
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke

Public Release: 8-Aug-2013
American Journal of Human Genetics
Genetic evidence shows recent population mixture in India
Researchers have found that modern-day India is the result of recent population mixture among divergent demographic groups.
National Institutes of Health, National Science Foundation, UKIERI Major Award, Network Project

Contact: David Cameron
david_cameron@hms.harvard.edu
617-432-0441
Harvard Medical School

Public Release: 6-Aug-2013
$20,000 Arizona Community Foundation grant helps fund TGen education
The Translational Genomics Research Institute (TGen) received another boost today for Science, Technology, Engineering and Math education with a $20,000 grant from the Arizona Community Foundation. TGen's Pathogen Genomics Division (TGen North) in Flagstaff secured the grant for the research institute's TGen2School program. At TGen North, some of the world's top experts study disease-causing microorganisms, including everything from valley fever to MRSA and even anthrax and plague.
Arizona Community Foundation

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute

Public Release: 5-Aug-2013
Annals of Internal Medicine
NYU Langone researchers offer new model, helping clinicians prioritize recommended preventive
With physicians facing increasing demands on their time, it can be extremely difficult to prioritize which preventive care methods should be used for their patients. Now, two researchers at NYU Langone Medical Center have developed a mathematical model that will save time, lead to enhanced care, and potentially save lives.
New York University School of Medicine

Contact: Lorinda Klein
lorindaann.klein@nyumc.org
212-404-3533
NYU Langone Medical Center / New York University School of Medicine

Public Release: 4-Aug-2013
Nature Chemical Biology
Researchers dismantle bacteria's war machinery
This is a veritable mechanics of aggression on the nanoscale. Certain bacteria, including Staphylococcus aureus, have the ability to deploy tiny darts. This biological weapon kills the host cell by piercing the membrane. Researchers at EPFL have dismantled, piece by piece, this intriguing little machine. Published in Nature Chemical Biology, this discovery offers new insight into the fight against pathogens that are increasingly resistant to antibiotics.

Contact: Matteo Dal Peraro
matteo.dalperaro@epfl.ch
41-798-083-220
Ecole Polytechnique Fédérale de Lausanne

Public Release: 2-Aug-2013
Cell
Wired for change
A study of gene expression led by scientists at the EMBL-European Bioinformatics Institute and the University of Cambridge has revealed the first steps of evolution in gene regulation in mice. Published in the journal Cell, the research has implications for the study of differences in gene regulation between people.
European Research Council, Marie Curie Re-Integration Award, EMBO Young Investigator Programme

Contact: Sonia Furtado Neves
sonia.furtado@embl.de
European Molecular Biology Laboratory

Public Release: 1-Aug-2013
Cell
How 'junk DNA' can control cell development
Researchers from the Gene and Stem Cell Therapy Program at Sydney's Centenary Institute have confirmed that, far from being "junk," the 97 percent of human DNA that does not encode instructions for making proteins can play a significant role in controlling cell development. And in doing so, the researchers have unravelled a previously unknown mechanism for regulating the activity of genes, increasing our understanding of the way cells develop and opening the way to new possibilities for therapy.
Centenary Institute

Contact: Tamzin Byrne
tamzin@scienceinpublic.com.au
043-297-4400
Centenary Institute

Public Release: 1-Aug-2013
Cell
Targeted therapy identified for protein that protects and nourishes cancer
UT MD Anderson scientists identify the first targeted therapy to block Skp2, which suppresses a cellular defense against cancer and activates glycolysis to feed tumors. The drug restores the senescence program and stifles glycolysis to thwart tumor progression.
NIH/National Cancer Institute, American Cancer Society, Susan G. Komen for the Cure

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center

Public Release: 1-Aug-2013
Cell
New designer compound treats heart failure by targeting cell nucleus
Researchers from Case Western Reserve University School of Medicine and the Dana-Farber Cancer Institute have made a fundamental discovery relevant to the understanding and treatment of heart failure -- a leading cause of death worldwide. The team discovered a new molecular pathway responsible for causing heart failure and showed that a first-in-class prototype drug, JQ1, blocks this pathway to protect the heart from damage.
National Institutes of Health

Contact: Jessica Studeny
Jessica.studeny@case.edu
216-368-4692
Case Western Reserve University

Public Release: 31-Jul-2013
Stem Cells
Computational biology: Cells reprogrammed on the computer
Scientists at the Luxembourg Centre for Systems Biomedicine of the University of Luxembourg have developed a model that makes predictions from which differentiated cells -- for instance skin cells -- can be very efficiently changed into completely different cell types -- such as nerve cells, for example. This can be done entirely without stem cells. These computer-based instructions for reprogramming cells are of huge significance for regenerative medicine. The LCSB researchers present their results today in the prestigious scientific journal "Stem Cells".

Contact: Britta Schlüter
britta.schlueter@uni.lu
352-466-644-6563
University of Luxembourg

Public Release: 31-Jul-2013
Wonders of nature inspire exotic man-made materials
In this month's edition of Physics World, a group of physicists describe how unique structures in the natural world are inspiring scientists to develop new types of materials with unprecedented properties.

Contact: Michael Bishop
michael.bishop@iop.org
01-179-301-032
Institute of Physics

Public Release: 31-Jul-2013
Ecological Society of America 2013 Annual Meeting
Entomological Society of America announces 2013 fellows
The Entomological Society of America has elected ten new Fellows of the Society for 2013. The election as a Fellow acknowledges outstanding contributions to entomology in research, teaching, extension, or administration.

Contact: Richard Levine
rlevine@entsoc.org
301-731-4535
Entomological Society of America

Public Release: 31-Jul-2013
New England Journal of Medicine
ITN achieves scientific manuscript first -- provides open, interactive access to clinical trial data
Immune Tolerance Network researchers published data of their "Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis (RAVE)" clinical trial using ITN TrialShare, a clinical trial data and analysis portal that provides open, unprecedented access to clinical trial data, analyses and specimens.

Contact: Philip Bernstein, Ph.D.
ITNCommunications@immunetolerance.org
240-235-6132
Immune Tolerance Network

Public Release: 29-Jul-2013
Chaos
Unraveling genetic networks
Now a special issue of the journal CHAOS, produced by AIP Publishing, explores new experimental and theoretical techniques for unraveling genetic networks.

Contact: Jason Socrates Bardi
jbardi@aip.org
240-535-4954
American Institute of Physics

Public Release: 26-Jul-2013
PhytoKeys
Database simplifies finding Canadian plant names and distribution
Determining the correct name of plants present in a particular area is often a chore to users of biodiversity information. VASCAN, the Database of Vascular plants of Canada, Saint Pierre and Miquelon, and Greenland, simplifies the task of finding such names, as well as the plant distribution at a regional level for all vascular plants established in the area covered.

Contact: Dr. Luc Brouillet
luc.brouillet@umontreal.ca
514-343-2142
Pensoft Publishers

Public Release: 25-Jul-2013
PLOS ONE
Microbial who-done-it for biofuels
A multi-institutional collaboration led by researchers with the Joint BioEnergy Institute and Joint Genome Institute has developed a promising technique for identifying microbial enzymes that can effectively deconstruct biomass into fuel sugars under refinery processing conditions.
US Department of Energy Office of Science

Contact: Lynn Yarris
lcyarris@lbl.gov
510-486-5375
DOE/Lawrence Berkeley National Laboratory

Public Release: 23-Jul-2013
HudsonAlpha awarded grant to improve diagnoses of childhood genetic disorders
Even in the absence of a ready solution, knowing why a child faces physical, emotional and intellectual challenges is helpful to physicians and families. Researchers at the HudsonAlpha Institute for Biotechnology are using high throughput genomic sequencing to meet major diagnostic needs for childhood genetic disorders through a multi-year grant potentially totaling more than $7.6 million from the National Institutes of Health. The study grant is part of the NIH's Clinical Sequencing Exploratory Research program.
NIH/National Human Genome Research Institute Clinical Sequencing Exploratory Research

Contact: Holly Ralston
hralston@hudsonalpha.org
256-508-8954
HudsonAlpha Institute for Biotechnology

Public Release: 22-Jul-2013
Diabetes
Could turning on a gene prevent diabetes?
The resistance to insulin seen in type 2 diabetics is caused partly by the lack of a protein that has not previously been associated with diabetes.
Association canadienne du diabète, Instituts de recherche en santé du Canada

Contact: William Raillant-Clark
rw.raillantclark@gmail.com
514-343-7593
University of Montreal

Public Release: 22-Jul-2013
Using GitHub as a repository for machine-readable scholarly articles
Pensoft now provides the XML of all articles in ZooKeys, PhytoKeys and MycoKeys in version-controlled repositories on GitHub for all to see, comment, improve and more. GitHub can be described as a social platform used mostly by software developers for coding, discussing, changing, and keeping track of all that. A major benefit of such re-use is that it acts as an additional check for quality.

Contact: Lyubomir Penev
info@pensoft.net
Pensoft Publishers

Public Release: 18-Jul-2013
Dartmouth researchers aim to discover the unknown causes of premature birth
Dartmouth researchers from the Institute for Quantitative Biomedical Sciences, the Center for Integrative Biomedical Sciences, and the Center for Genomic Medicine at the Geisel School of Medicine are studying the unknown causes of premature birth, as part of a $10 million March of Dimes grant. Scott Williams, Jason Moore and Christopher Amos will examine diverse world populations with different levels of premature birth to understand how genetic variation impacts the underlying biology of preterm birth.
March of Dimes

Contact: Derik Hertel
kenneth.d.hertel@dartmouth.edu
603-650-1211
The Geisel School of Medicine at Dartmouth

Public Release: 18-Jul-2013
Genes & Development
Newly found CLAMP protein regulates genes
A newly discovered protein, found in many species, turns out to be the missing link that allows a key regulatory complex to find and operate on the lone X chromosome of male fruit flies, bringing them to parity with females. Called CLAMP, the protein provides a model of how such regulatory protein complexes find their chromosome targets.
National Institutes of Health, National Science Foundation, Pew Biomedical Scholars Program, Rhode Island Foundation

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 15-Jul-2013
Clinical trials for cancer, 1 patient at a time
New department at Columbia University Medical Center is developing a different approach to cancer clinical trials, in which therapies are designed and tested one patient at a time. The patient's tumor is "reverse engineered" to determine its unique genetic characteristics and to identify existing US Food and Drug Administration-approved drugs that may target them.

Contact: Karin Eskenazi
ket2116@columbia.edu
212-305-3900
Columbia University Medical Center

Public Release: 11-Jul-2013
AMP concerned about the structure and application of gap fill payment amounts
The Association for Molecular Pathology submitted comments to the Centers for Medicare and Medicaid Services expressing serious concerns about the gap fill process.

Contact: Catherine Davidge
cdavidge@amp.org
301-634-7400
Association for Molecular Pathology

Showing releases 476-500 out of 714.

<< < 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 > >>